Kralli A, Ge R, Graeven U, Ricciardi R P, Weinmann R
Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104.
J Virol. 1992 Dec;66(12):6979-88. doi: 10.1128/JVI.66.12.6979-6988.1992.
In cells transformed by the highly oncogenic adenovirus type 12 (Ad12), the viral E1A proteins mediate transcriptional repression of the major histocompatibility class I genes. In contrast, class I transcription is not reduced in cells transformed by the nononcogenic Ad5. The decreased rate of class I transcription is, at least in part, the result of a reduced major histocompatibility complex class I enhancer activity in Ad12-transformed cells and correlates with an increase in the levels of a DNA-binding activity to the R2 element of the enhancer (R. Ge, A. Kralli, R. Weinmann, and R. P. Ricciardi, J. Virol. 66:6969-6978, 1992). Employing transient transfection assays, we now provide direct evidence that the R2 element can confer repression in Ad12- but not Ad5-transformed cells. Repression by R2 was observed only in the presence of the positive enhancer element R1 and was dependent on (i) the number of the R2 elements and (ii) the relative arrangement of R2 and R1 elements. The putative R2-binding repressor protein, R2BF, was similar in molecular weight and binding specificity to members of the thyroid hormone/retinoic acid (RA) receptor family. RA treatment abrogated the R2-mediated repression in Ad12-transformed cells and had no effect on the activity of R2/R1-containing promoters in Ad5-transformed cells. These results are consistent with the presence of an R2-binding repressor in Ad12-transformed cells. In the absence of RA, the repressor compromises enhancer activity by interfering with the activity of the positive cis element R1. RA treatment of Ad12-transformed cells may render the repressor inactive.
在被高致癌性12型腺病毒(Ad12)转化的细胞中,病毒E1A蛋白介导主要组织相容性复合体I类基因的转录抑制。相比之下,在被非致癌性Ad5转化的细胞中,I类转录并未降低。I类转录速率的降低至少部分是由于Ad12转化细胞中主要组织相容性复合体I类增强子活性降低,并且与增强子R2元件的DNA结合活性水平增加相关(R. 葛、A. 克拉利、R. 魏曼和R. P. 里恰尔迪,《病毒学杂志》66:6969 - 6978,1992)。利用瞬时转染分析,我们现在提供直接证据表明R2元件可在Ad12转化而非Ad5转化的细胞中导致抑制。仅在存在阳性增强子元件R1时观察到R2的抑制作用,并且其依赖于(i)R2元件的数量以及(ii)R2和R1元件的相对排列。假定的R2结合阻遏蛋白R2BF在分子量和结合特异性上与甲状腺激素/视黄酸(RA)受体家族成员相似。RA处理消除了Ad12转化细胞中R2介导的抑制作用,并且对Ad5转化细胞中含R2/R1的启动子活性没有影响。这些结果与Ad12转化细胞中存在R2结合阻遏物一致。在没有RA的情况下,该阻遏物通过干扰阳性顺式元件R1的活性而损害增强子活性。对Ad12转化细胞进行RA处理可能会使该阻遏物失活。